reduce basal insulin dose when starting glp-1 receptor agonist Adding a was not associated with a lower likelihood of discontinuing existing therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation GLP-1 receptor agonists in the

Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.

Discover the research, how they work, who should try these, and more.

/PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly...

Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more...

Learn key patient education tips for GLP-1 care management, the importance of multidisciplinary care teams and how remote care providers fit into the equation.